356 related articles for article (PubMed ID: 32664415)
1. Nucleophosmin in Its Interaction with Ligands.
Cela I; Di Matteo A; Federici L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664415
[TBL] [Abstract][Full Text] [Related]
2. Proteomics analysis identifies the ribosome associated coiled-coil domain-containing protein-124 as a novel interaction partner of nucleophosmin-1.
Çakırca G; Öztürk MT; Telkoparan-Akillilar P; Güllülü Ö; Çetinkaya A; Tazebay UH
Biol Cell; 2024 Jan; 116(1):e202300049. PubMed ID: 38029384
[TBL] [Abstract][Full Text] [Related]
3. Molecules that target nucleophosmin for cancer treatment: an update.
Di Matteo A; Franceschini M; Chiarella S; Rocchio S; Travaglini-Allocatelli C; Federici L
Oncotarget; 2016 Jul; 7(28):44821-44840. PubMed ID: 27058426
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.
Federici L; Falini B
Protein Sci; 2013 May; 22(5):545-56. PubMed ID: 23436734
[TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia.
Shi Y; Xue Y; Wang C; Yu L
Hematology; 2022 Dec; 27(1):609-619. PubMed ID: 35621728
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.
Chiarella S; De Cola A; Scaglione GL; Carletti E; Graziano V; Barcaroli D; Lo Sterzo C; Di Matteo A; Di Ilio C; Falini B; Arcovito A; De Laurenzi V; Federici L
Nucleic Acids Res; 2013 Mar; 41(5):3228-39. PubMed ID: 23328624
[TBL] [Abstract][Full Text] [Related]
7. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the recognition by 14-3-3 proteins of a conditional binding site within the oligomerization domain of human nucleophosmin.
Kapitonova AA; Tugaeva KV; Varfolomeeva LA; Boyko KM; Cooley RB; Sluchanko NN
Biochem Biophys Res Commun; 2022 Oct; 627():176-183. PubMed ID: 36041327
[TBL] [Abstract][Full Text] [Related]
9. NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions.
Falini B
Am J Hematol; 2023 Sep; 98(9):1452-1464. PubMed ID: 37317978
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
Rau R; Brown P
Hematol Oncol; 2009 Dec; 27(4):171-81. PubMed ID: 19569254
[TBL] [Abstract][Full Text] [Related]
11. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
12. Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Ranieri R; Pianigiani G; Sciabolacci S; Perriello VM; Marra A; Cardinali V; Pierangeli S; Milano F; Gionfriddo I; Brunetti L; Martelli MP; Falini B
Leukemia; 2022 Oct; 36(10):2351-2367. PubMed ID: 36008542
[TBL] [Abstract][Full Text] [Related]
13. Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis.
Zhang MJ; Ding YL; Xu CW; Yang Y; Lian WX; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Ning HM; Li CY; Yang XM
FEBS J; 2012 Aug; 279(16):2848-62. PubMed ID: 22712502
[TBL] [Abstract][Full Text] [Related]
14. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
16. Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.
Nemeckova S; Alexova-Zurkova K; Hainz P; Krystofova J; Mackova J; Roubalova K; Stastna-Markova M; Vrana M; Vydra J
Curr Oncol; 2022 Apr; 29(5):2928-2934. PubMed ID: 35621629
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair.
López DJ; Rodríguez JA; Bañuelos S
Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140532. PubMed ID: 32853771
[TBL] [Abstract][Full Text] [Related]
18. Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.
Florio D; Roviello V; La Manna S; Napolitano F; Maria Malfitano A; Marasco D
Bioorg Chem; 2022 Oct; 127():106001. PubMed ID: 35803020
[TBL] [Abstract][Full Text] [Related]
19. Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ.
Di Matteo A; Franceschini M; Paiardini A; Grottesi A; Chiarella S; Rocchio S; Di Natale C; Marasco D; Vitagliano L; Travaglini-Allocatelli C; Federici L
Oncogenesis; 2017 Sep; 6(9):e379. PubMed ID: 28920929
[TBL] [Abstract][Full Text] [Related]
20. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
